Centre Hospitalier Universitaire de Nantes, Hôpital Hôtel Dieu
Nantes 44093
0 studies enrolling now · 2 studies all time
What they study most
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Melanoma